THOMPSON ONCOLOGY DEVICES

Thompson Oncology Devices LLC was formed in 2018 to advance the immunotherapy device invented by Mark D. Howell, Ph.D., at Colorado State University in Fort Collins. With support from CSU Research Foundation, Dr. Howell's discoveries led to the UNLEASH® technology, a powerful experimental tool that represents a new approach to treating a wide spectrum of cancerous tumors. The extracorporeal device effectively up-regulates immune system signaling molecules (cytokines) by selective filtration of inhibitor proteins from plasma. The company seeks to gain FDA and CE approval for the device.

Also known as: Thompson Oncology, Thompson Oncology Devices LLC